Jazz Pharmaceuticals
JAZZ
JAZZ
407 hedge funds and large institutions have $5B invested in Jazz Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 124 increasing their positions, 171 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $27.2M
36% less capital invested
Capital invested by funds: $7.76B → $5B (-$2.77B)
40% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 85
Holders
407
Holding in Top 10
4
Calls
$18.3M
Puts
$27.2M
Top Buyers
| 1 | +$50.3M | |
| 2 | +$38.7M | |
| 3 | +$32.1M | |
| 4 |
Holocene Advisors
New York
|
+$29.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$15.7M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$43.1M | |
| 3 | -$41M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$35.7M |
| 5 |
D.E. Shaw & Co
New York
|
-$25.5M |